ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,999.10
-0.23%
S&P ASX All Technology
3,180.20
0.48%
Brent Oil
84.055
-0.34%
US Dollar vs AUD
1.4825
0.26%
Bitcoin
64,624.72
-0.35%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Pfizer Inc (0Q1N)

  7. Pfizer Inc (0Q1N) News

0Q1N

Pfizer (0Q1N)

Pfizer Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0Q1N
DateTimeSourceHeadlineSymbolCompany
15/09/202021:54Alliance NewsAlliance NewsMylan And Upjohn Combination Gets European Green LightLSE:0Q1NPfizer Inc
10/09/202000:07Alliance NewsAlliance NewsPfizer And BioNTech Announce Promising Covid-19 Vaccine Study DataLSE:0Q1NPfizer Inc
25/08/202014:31Alliance NewsAlliance NewsReshuffling The Dow: Exxon, Pfizer Out; Salesforce, Amgen InLSE:0Q1NPfizer Inc
21/08/202016:21Alliance NewsAlliance NewsTOP NEWS: Pfizer, BioNTech Target Covid-19 Vaccine Review For OctoberLSE:0Q1NPfizer Inc
12/08/202021:33Alliance NewsAlliance NewsPfizer Virus Vaccine Candidate Induces Immune Response, Trial ShowsLSE:0Q1NPfizer Inc
06/08/202003:03Alliance NewsAlliance NewsCanada Strikes Deals For Vaccine Candidates With Pfizer, ModernaLSE:0Q1NPfizer Inc
28/07/202023:28Alliance NewsAlliance NewsTOP NEWS: Pfizer Raises Annual Guidance Despite Weak Second QuarterLSE:0Q1NPfizer Inc
22/07/202022:44Alliance NewsAlliance NewsTOP NEWS: US Commits USD1.95 Billion To Pfizer-BioNTech Covid VaccineLSE:0Q1NPfizer Inc
02/07/202001:59Alliance NewsAlliance NewsPfizer, BioNTech Report Progress In Coronavirus Vaccine TrialLSE:0Q1NPfizer Inc
15/06/202015:42Alliance NewsAlliance NewsGlaxo And Pfizer's ViiV Gets US FDA Approval For Tivicay PD TabletsLSE:0Q1NPfizer Inc
18/05/202017:04Alliance NewsAlliance NewsTOP NEWS: Glaxo Reports Positive Results From Viiv's HIV Drug StudyLSE:0Q1NPfizer Inc
28/04/202021:55Alliance NewsAlliance NewsTOP NEWS: Departing Upjohn Hurts Pfizer; Ups Spend On Covid-19 VaccineLSE:0Q1NPfizer Inc
23/04/202003:59Alliance NewsAlliance NewsTOP NEWS: EU Approves Merger Of Pfizer Off-Patent Unit And MylanLSE:0Q1NPfizer Inc
28/02/202001:19Alliance NewsAlliance NewsMylan, Pfizer Pick Finance Chief For Viatris; Complete Board HiresLSE:0Q1NPfizer Inc
29/01/202001:36Alliance NewsAlliance NewsPfizer Quarterly Loss Hurt By Upjohn Sales Dip; Excited For New PfizerLSE:0Q1NPfizer Inc
14/01/202001:28Alliance NewsAlliance NewsPfizer Could Net USD635 Million As Biogen Acquires Alzheimer's DrugLSE:0Q1NPfizer Inc
21/12/201922:40Alliance NewsAlliance NewsUS FDA Rejects New Drug Application For ViiV Healthcare HIV TreatmentLSE:0Q1NPfizer Inc
05/12/201923:20Alliance NewsAlliance NewsGlaxo's ViiV Healthcare Submits Application For Fostemsavir ApprovalLSE:0Q1NPfizer Inc
09/11/201902:13Alliance NewsAlliance NewsMerck And Pfizer's Avelumab Javelin Study Fails To Meet Main EndpointsLSE:0Q1NPfizer Inc
30/10/201900:39Alliance NewsAlliance NewsPfizer Revenue Down On Glaxo Deal, US Drug Exclusivity LossLSE:0Q1NPfizer Inc
21/10/201916:16Alliance NewsAlliance NewsPfizer Accelerates Vincristine Supply In US To Meet Long-Term DemandLSE:0Q1NPfizer Inc
08/10/201902:32Alliance NewsAlliance NewsPfizer Signs Licensing Deal With Akcea, Ionis For AKCEA-ANGPTL3-LRxLSE:0Q1NPfizer Inc
21/09/201903:08Alliance NewsAlliance NewsPfizer Notes Positive Opinion On Kidney Cancer Drug Bavencio In EuropeLSE:0Q1NPfizer Inc
02/09/201920:33Alliance NewsAlliance NewsBristol-Myers Squibb Reports Positive Results In Joint Venture TrialLSE:0Q1NPfizer Inc
22/08/201917:20Alliance NewsAlliance NewsGlaxo's ViiV Reports Positive Study Results Of HIV-Treatment RegimenLSE:0Q1NPfizer Inc
15/08/201916:00Alliance NewsAlliance NewsPfizer Recalls Headache Tablets Following Potential ContaminationLSE:0Q1NPfizer Inc
30/07/201922:13Alliance NewsAlliance NewsPfizer First Half Revenue Flat; Updates Guidance On Glaxo VentureLSE:0Q1NPfizer Inc
30/07/201904:09Alliance NewsAlliance NewsMoody's Puts Pfizer On Downgrade Review Over Upjohn SeparationLSE:0Q1NPfizer Inc
29/07/201922:22Alliance NewsAlliance NewsPfizer To Combine Off-Patent Drug Unit Upjohn With MylanLSE:0Q1NPfizer Inc
29/07/201915:38Alliance NewsAlliance NewsPRESS: Pfizer In Talks Over Off-Patent Drugs Merger With MylanLSE:0Q1NPfizer Inc
 Showing the most relevant articles for your search:LSE:0Q1N

Your Recent History

NYSE
VZ
Verizon Communications
NYSE
MCD
McDonalds
ASX
CSL
CSL
NASDAQ
AMZN
Amazon.com
NYSE
JPM
JP Morgan Chase
NYSE
KO
Coca Cola
NYSE
MRK
Merck
ASX
BHP
BHP
ASX
MQG
Macquarie
NASDAQ
MSFT
Microsoft
PM
XAUUSD
Gold vs US Dollar
ASX
NAB
National Australia Bank
ASX
FMG
Fortescue
ASX
TLS
Telstra
ASX
XTO
S&P ASX 100
FX
AUDJPY
AUD vs Yen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved